Cargando…

NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways—Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases

Fatigue is a widespread and complex symptom with motor and cognitive components; it is diagnosed predominantly by questionnaire. We recently published a correlation between anti-N-methyl-D-aspartate receptor (NMDAR) antibodies and fatigue in patients with SLE (systemic lupus erythematosus). In the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marinoska, Tatjana, Möckel, Tamara, Triantafyllias, Konstantinos, Boegel, Sebastian, Dreher, Matthias, Luessi, Felix, Schwarting, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964077/ https://www.ncbi.nlm.nih.gov/pubmed/36834970 http://dx.doi.org/10.3390/ijms24043560

Ejemplares similares

Optical spectral transmission to assess glucocorticoid therapy response in patients with arthritis: a longitudinal follow-up comparison with joint ultrasound
por: Triantafyllias, Konstantinos, et al.
Publicado: (2023)

Case Report: Cotard's Syndrome in Anti-N-methyl D-aspartate (NMDA) Receptor (Anti-NMDAR) Encephalitis
por: Taib, Nur Iwana Abdul, et al.
Publicado: (2022)

Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice
por: Möckel, Tamara, et al.
Publicado: (2023)

Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
por: Chen, Shuang, et al.
Publicado: (2022)

Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future
por: Mandel, Anna, et al.
Publicado: (2022)

Patients with Rheumatic Diseases do not have an Increased Risk of MRSA Carrier Status
por: Krämer, Judith, et al.
Publicado: (2018)

Anti-n-Methyl-d-Aspartate-Receptor (NMDAR) Encephalitis in Association with Ovarian Teratoma
por: Ahmad, Javaad, et al.
Publicado: (2017)

Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics
por: Ly, Lam-Thanh, et al.
Publicado: (2018)

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
por: Hopfner, Franziska, et al.
Publicado: (2019)

Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease
por: Ehrenreich, Hannelore
Publicado: (2018)

Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay
por: Chiu, Nan-Chang, et al.
Publicado: (2018)

Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
por: Wang, Hao, et al.
Publicado: (2020)

38.3 ONGOING GERMINAL CENTRE REACTIONS CONTRIBUTE TO N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTIBODY PRODUCTION IN NMDAR-ANTIBODY ENCEPHALITIS
por: Makuch, Mateusz, et al.
Publicado: (2018)

NMDAR autoantibodies in psychiatric disease - An immunopsychiatric continuum and potential predisposition for disease pathogenesis
por: Hansen, Niels
Publicado: (2022)

Anti N-methyl-D-aspartate receptor (NMDAr) encephalitis during pregnancy: A case report
por: Dono, Fedele, et al.
Publicado: (2022)

Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine
por: Kalatharan, Veberka, et al.
Publicado: (2023)

Autoantibody Biomarkers in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2020)

NYX‐2925 induces metabotropic N‐methyl‐d‐aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor
por: Bowers, M. Scott, et al.
Publicado: (2019)

Autoantibodies detection in anti-N-methyl-D-aspartate receptor encephalitis
por: Li, Jiayu, et al.
Publicado: (2021)

Selective Vulnerabilities of N-methyl-D-aspartate (NMDA) Receptors During Brain Aging
por: Magnusson, Kathy R., et al.
Publicado: (2010)

N-methyl-D-aspartate (NMDA) receptor expression and function is required for early chondrogenesis
por: Matta, Csaba, et al.
Publicado: (2019)

Autoantibody Profiles in Autoimmune Rheumatic Diseases
por: Bizzaro, Nicola
Publicado: (2019)

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients
por: Jézéquel, Julie, et al.
Publicado: (2017)

The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies
por: Ellul, Pierre, et al.
Publicado: (2017)

Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis
por: Wilke, Justus B. H., et al.
Publicado: (2021)

Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis
por: Zhang, Min, et al.
Publicado: (2019)

Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them
por: Fani, Giulia, et al.
Publicado: (2021)

Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis Associated With Mediastinal and Ovarian Teratomas: A Case Report
por: Lee, Sue Hyun, et al.
Publicado: (2023)

Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis
por: Beck, Katherine, et al.
Publicado: (2015)

Thyroid Autoantibody Positive Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Jung, Yoori, et al.
Publicado: (2016)

Serum Systemic Autoantibodies in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Zhang, Bingjun, et al.
Publicado: (2020)

Dysfunction of NMDA receptors in Alzheimer’s disease
por: Zhang, Yan, et al.
Publicado: (2016)

The Role of NMDA Receptors in Alzheimer’s Disease
por: Liu, Jinping, et al.
Publicado: (2019)

Editorial: NMDA receptors in physiology and disease
por: Baez, María Verónica, et al.
Publicado: (2023)

Anti N‐Methyl‐D‐Aspartate (NMDA) receptor encephalitis: from psychosis to cognitive impairment
por: Vahabi, Zahra, et al.
Publicado: (2021)

Differential Regulation of GABA(B) Receptor Trafficking by Different Modes of N-methyl-d-aspartate (NMDA) Receptor Signaling
por: Kantamneni, Sriharsha, et al.
Publicado: (2014)

Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
por: Pozzi, Laura, et al.
Publicado: (2014)

Emerging technologies in autoantibody testing for rheumatic diseases
por: Olsen, Nancy J., et al.
Publicado: (2017)

Prion Protein Is a Key Determinant of Alcohol Sensitivity through the Modulation of N-Methyl-D-Aspartate Receptor (NMDAR) Activity
por: Petit-Paitel, Agnès, et al.
Publicado: (2012)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s71aflvovur8eid7pe9k9ta3sr